Realcan Pharmaceutical Group Co Ltd operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Realcan Pharmaceutical Group Co Ltd with three other
companies in this sector in China:
Zhejiang International Group Company Limited
sales of 18.91 billion Chinese Renmimbi [US$2.80 billion]
of which 100%
was Medicine Retailing),
C.Q. Pharmaceutical Holding Co Ltd
(23.04 billion Chinese Renmimbi [US$3.41 billion]
of which 92%
was Drug Sales), and
Yunnan Baiyao Group Co., Ltd.
(24.31 billion Chinese Renmimbi [US$3.60 billion]
of which 59%
was Comodities Trading).
Realcan Pharmaceutical Group Co Ltd reported sales of 23.29 billion Chinese Renmimbi (US$3.45 billion)
December of 2017.
increase of 49.1%
versus 2016, when the company's sales were 15.62 billion Chinese Renmimbi.
Sales at Realcan Pharmaceutical Group Co Ltd have increased during each of the previous five years
(and since 2012, sales have increased a total of 404%).
Sales of Medical Services saw an increase
67.2% in 2017, from
19.68 million Chinese Renmimbi to 32.92 million Chinese Renmimbi.